Literature DB >> 6651909

Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.

A Noma, T Yokosuka, K Kitamura.   

Abstract

The relationship of coronary artery disease to with plasma lipids and apolipoproteins was examined in 100 male patients aged 32-69 years undergoing coronary angiography for suspected myocardial infarction. Patients with angiographically defined coronary artery disease had significantly lower plasma levels of high density lipoprotein (HDL) cholesterol, apolipoproteins A-I and A-II, and significantly higher values of low density lipoprotein (LDL) cholesterol and apolipoprotein B than those in patients without coronary artery disease. The ratios derived from the measurements as LDL cholesterol/HDL cholesterol, apo B/apo A-I and apo B/apo A-II were highly significantly increased in the patients with coronary artery disease. Coronary score values, by which the severity of coronary artery disease was quantified, were not related to plasma levels of the HDL components, while they were positively correlated with those of the LDL components. These results suggest that, in single measurements, plasma levels of the HDL components, HDL-cholesterol and apo A-I, contribute strongly to the discrimination between patients with coronary artery disease and those without this disease, whereas the LDL components, LDL-cholesterol and apo B are more suitable parameters for the severity of the disease than are the HDL components. The ratios of LDL cholesterol/HDL cholesterol, apo B/apo A-I and apo B/apo A-II were powerful discriminators for either presence or severity of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651909     DOI: 10.1016/0021-9150(83)90002-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Dissimilar properties of vaccenic versus elaidic acid in beta-oxidation activities and gene regulation in rat liver cells.

Authors:  Zhen-Yu Du; Pascal Degrace; Joseph Gresti; Olivier Loreau; Pierre Clouet
Journal:  Lipids       Date:  2010-05-28       Impact factor: 1.880

2.  Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.

Authors:  J N Mount; E M Kearney; M Rosseneu; B M Slavin
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

3.  Serum lipoproteins in day and shift workers: a prospective study.

Authors:  A Knutson; H Andersson; U Berglund
Journal:  Br J Ind Med       Date:  1990-02

4.  Benefits and problems of a physical training programme for asthmatic patients.

Authors:  L M Cochrane; C J Clark
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

5.  Apolipoprotein A and prognosis after myocardial infarction in non-diabetic men.

Authors:  H Pollak; O Arnoldner; W Enenkel; M Fischer; D Trubert-Exinger
Journal:  Klin Wochenschr       Date:  1991-01-04

Review 6.  The effect of exercise on lipid metabolism in men and women.

Authors:  L Goldberg; D L Elliot
Journal:  Sports Med       Date:  1987 Sep-Oct       Impact factor: 11.136

7.  Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus.

Authors:  A J MacGregor; V B Dhillon; A Binder; C A Forte; B C Knight; D J Betteridge; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

8.  Familial disorders of plasma apolipoproteins.

Authors:  C R Sirtori; G Franceschini
Journal:  Klin Wochenschr       Date:  1985-06-03

9.  Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E.

Authors:  J Osuga; M Yonemoto; N Yamada; H Shimano; H Yagyu; K Ohashi; K Harada; T Kamei; Y Yazaki; S Ishibashi
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

10.  Association of apolipoprotein b/apolipoprotein A1 ratio and coronary artery stenosis and plaques detected by multi-detector computed tomography in healthy population.

Authors:  Chang Hee Jung; Jenie Yoonoo Hwang; Mi Seon Shin; Ji Hee Yu; Eun Hee Kim; Sung Jin Bae; Dong Hyun Yang; Joon-Won Kang; Joong-Yeol Park; Hong-Kyu Kim; Woo Je Lee
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.